Academic Palliative Care

描述（由申请人提供）：Charles F. von Gunten，MD，PhD正在寻求支持作为姑息治疗的既定研究者，这是国家癌症研究所预防和控制计划的一部分。 姑息治疗可以概括为预防和减轻痛苦。 作为一名拥有资助研究、同行评审出版物和指导记录的知名研究者，他现在处于独特的地位，可以促进该领域的进一步发展，正如医学研究所和国家癌症政策委员会最近的报告所呼吁的那样。 作为圣地亚哥临终关怀与姑息治疗中心姑息研究主任，加州圣地亚哥大学医学院的教学和研究附属机构，NCI指定的加州圣地亚哥摩尔综合癌症中心的成员，EPEC项目的共同负责人，姑息医学杂志的高级副主编和主席，美国临终关怀和姑息医学委员会，NCI能够保护他的能力，进行姑息治疗研究和指导学员和领导人在该领域。 他追求的研究目标是了解教育（特别是医生）和症状控制（特别是神经性疼痛），以及广泛的宣传和领导目标，以实现他的目标。 科学支持的预防和减轻痛苦的方法对于癌症患者及其家人的整体护理与癌症本身的治疗方法一样重要。 他需要保护的时间来继续一个重要的研究计划，在创造和传播姑息治疗知识和重新进入新的医生科学家在该领域。 他负责美国最大的亚专科姑息医学医师部门的教育和研究发展。 此外，他还负责以类似的方式培养和发展执业护士、护士、社会工作者和牧师。 他的个人研究计划解决了这个问题：“如何最好地教授姑息治疗？“这K05将允许他进行教育研究的住院医生，医生研究员，护士，社会工作者和牧师。 该K05将允许他指导初级研究人员在项目中测试输注利多卡因缓解严重难治性疼痛的能力，了解晚期疾病患者，家属，工作人员的沟通，并测试针灸缓解晚期疾病患者痛苦的能力。 所有重新进入的研究人员都在寻求NCI的资助，并有可能成为独立的研究人员。

DESCRIPTION (provided by applicant): Charles F. von Gunten, MD, PhD is seeking support as an established investigator in palliative care, part of National Cancer Institute's prevention and control program. Palliative care can be summarized as the prevention and relief of suffering. As an established investigator with a track record of funded research, peer-reviewed publications and mentoring, he is now in a unique position to foster further development of the field as called for in the recent reports by the Institute of Medicine and National Cancer Policy Board. In roles as Director of the Center for Palliative Studies at San Diego Hospice & Palliative Care, a teaching and research affiliate of the University of California San Diego School of Medicine, member of the NCI-designated University of California San Diego Moores Comprehensive Cancer Center, Co-Principal of the EPEC Project, Senior Associate Editor of the Journal of Palliative Medicine and Chairman, American Board of Hospice and Palliative Medicine, the NCI is able to protect his abilities to conduct palliative care research and mentor trainees and leaders in the field. He has pursued research objectives to understand education (particularly physicians) and symptom control (particularly neuropathic pain) and as well as broad advocacy and leadership objectives to achieve his goals. Scientifically supported approaches to the prevention and relief of suffering are as important to the overall care of patients with cancer and their families as are approaches to the treatment of cancer itself. He needs protected time to continue a vital research program in the creation and dissemination of palliative care knowledge and reentering new physician scientists in the field. He is responsible for the educational and research developments in the largest department of subspecialist palliative medicine physicians in the USA. In addition, he is responsible for nurturing and developing nurse practitioners, nurses, social workers, and chaplains in a similar way. His personal research plan addresses the question "How is palliative care best taught?" This K05 will permit him to conduct educational research for resident physicians, physician fellows, nurses, social workers and chaplains. This K05 will permit him to mentor junior investigators in projects to test the ability of infusional lidocaine to relieve severe refractory pain, to understand patient, family, staff communication in terminal illness, and to test the ability of acupuncture to relieve distress in patients with terminal illness. All reentered investigators are seeking NCI funding and have the potential to become independent investigators.